This retrospective study analyzes the clinical presentation, diagnosis, management, and outcomes of 201 patients with intracranial suppurations at Donka National Hospital in Guinea. The authors report ...

House Republicans killed a Democratic bill intended to strengthen the reporting of test scores for students in the education ...

Background A growing arsenal of treatment options for relapsing multiple sclerosis (RMS) emphasises the need for early prognostic biomarkers. While evidence for individual markers exists, ...

For decades, confirming Alzheimer’s disease has meant invasive spinal taps, expensive brain scans, and, too often, waiting until memory loss is unmistakable. Now researchers and regulators are ...

Shareholder/Analyst Call February 5, 2026 3:30 PM ESTCompany ParticipantsRyan Watts - Co-Founder, President, CEO ...

JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR"), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today announced the presentation of four ...

The idea of diagnosing Alzheimer’s with a quick, finger-prick test marks a profound shift in how we could approach neurodegenerative diseases. Moving beyond invasive, costly procedures toward ...

NEW YORK – Breast cancer researchers at the Dana-Farber Cancer Institute and Harvard Cancer Center are investigating whether a CSF-1R inhibitor can overcome PARP inhibitor resistance associated with ...

Last month, The US Food and Drug Administration approved a new blood test for assisting the diagnosis of Alzheimer’s disease. Produced by Roche, Elecsys pTau181 measures the concentration of a ...

Objective: To analyze the clinical characteristics and cerebrospinal fluid (CSF) biochemical indexes, tumor markers (TM) and cytomorphological indexes of patients with meningeal carcinomatosis (MC), ...